TB-500, a synthetic version of the naturally occurring Thymosin Beta-4 peptide fragment, appears to promote cell migration, differentiation, and wound healing by regulating actin polymerization and increasing vascular endothelial growth factor (VEGF) activity
10.1016/j.bbabio.2010.02.010 Biochim
Normal activities can be resumed immediately after
It has been investigated across dermal-matrix remodelling, wound healing, antioxidant chemistry, and gene-expression-profiling literature streams
Regulatory and Ethical Considerations Current Approval Status (2026) As of 2026, neither cagrilintide nor retatrutide has received FDA approval for obesity treatment or metabolic applications
Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase